Cancer and post-traumatic stress disorder: Diagnosis, pathogenesis and treatment considerations

Palliative and Supportive Care

Volumn 10, Issue 3, 2012, Pages 213-223

  Rustad, James K ^a   David, Daniella ^a   Currier, M Beatriz ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Cancer; Drug interactions; Epidemiology; Pathophysiology; PTSD

Indexed keywords

ANTINEOPLASTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; COMORBIDITY; DRUG INTERACTION; HUMAN; NEOPLASM; POSTTRAUMATIC STRESS DISORDER;

ADULT; ANTINEOPLASTIC AGENTS; COMORBIDITY; DRUG INTERACTIONS; HUMANS; NEOPLASMS; PSYCHOTROPIC DRUGS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84865725320     PISSN: 14789515     EISSN: 14789523     Source Type: Journal    
DOI: 10.1017/S1478951511000897     Document Type: Article

References (65)

1. Ahmadi, N., Hajsadeghi, F., Mirshkarlo, H.B., et al. (2010). Post-traumatic stress disorder, coronary atherosclerosis, and mortality. The American Journal of Cardiology, 108, 29-33.
2. Alter, C.L., Pelcovitz, D., Axelrod, A., et al. (1996). Identification of PTSD in Cancer Survivors. Psychosomatics, 37, 137-143. (Pubitemid 26066259)
3. American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association Publishing.
4. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association Publishing.
5. American Psychiatric Association Work Group on ASD and PTSD. (2004). Practice guidelines for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Washington, DC: American Psychiatric Association Publishing.
6. Andrykowski, M.A. (1994). Psychiatric and psychosocial aspects of bone marrow transplantation. Psychosomatics, 35, 13-24. (Pubitemid 24007048)
7. Antoni, M.H., Wimberly, S.R., Lechner, S.C., et al. (2006). Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. American Journal of Psychiatry, 163, 1791-1797. (Pubitemid 44522489)
8. Asmundson, G.J.G., Frombach, I., McQuaid, J., et al. (2000). Dimensionality of posttraumatic stress symptoms: A confirmatory factor analysis of DSM-IV symptom clusters and other symptom models. Behaviour Research and Therapy, 38, 203-214. (Pubitemid 29512186)
9. Baker, F., Zabora, J., Polland, A., et al. (1999). Reintegration after bone marrow transplantation. Cancer Practice, 7, 190-197. (Pubitemid 29330113)
10. Beijnen, J.H. & Schellens, J.H.M. (2004). Drug interactions in oncology. The Lancet Oncology, 5, 489-496. (Pubitemid 39069399)
11. Bisson, J.I., Ehlers, A., Matthews, R., et al. (2007). Psychological treatments for chronic post-traumatic stress disorder: Systematic review and meta-analysis. British Journal of Psychiatry, 190, 97-104.
12. Breitbart,W. & Heller, K.S. (2003). Reframing hope: Meaning-centered care for patients near the end of life. Journal of Palliative Medicine, 6, 979-988. (Pubitemid 38133260)
13. Breitbart, W., Rosenfield, B., Gibson, C., et al. (2010). Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psycho-oncology, 19, 21-28.
14. Buckley, T.C. & Kaloupek, D.J. (2001). A meta-analytic examination of basal cardiovascular functioning in PTSD. Psychosomatic Medicine, 63, 585-594. (Pubitemid 32695139)
15. Buckley, T.C., Mozley, S.L., Bedard, M.A., et al. (2004). Preventive health behaviors, health-risk behaviors, physical morbidity, and health-related role functioning impairment in veterans with post-traumatic stress disorder. Military Medicine, 169, 536-540. (Pubitemid 40247462)
16. Capuron, L., Pagnoni, G., Demetrashvilli, M., et al. (2005). Anterior cingulate activation and error processing during interferon-alpha treatment. Biological Psychiatry, 58, 190-196. (Pubitemid 41112266)
17. Classen, C., Butler, L.D., Koopman, C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494-501. (Pubitemid 32411331)
18. Cordova, M.J. & Andrykowski M.A. (2003). Responses to cancer diagnosis and treatment: posttraumatic stress and posttraumatic growth. Seminars in Clinical Neuropsychiatry, 8, 286-296. (Pubitemid 37474737)
19. Cordova, M.J., Studts, J.L., Hann, D.M., et al. (2000). Symptom structure of PTSD following breast cancer. Journal of Traumatic Stress, 13, 301-319. (Pubitemid 30333798)
20. Davidson, J.R.T., Brady, K., Mellman, T.A., et al. (2007). The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. Journal of Clinical Psychopharmacology, 27, 85-88. (Pubitemid 46105772)
21. Davidson, J.R.T., Connor, K.M. & Zhang, W. (2009). Treatment of anxiety disorders. In: Textbook of Psychopharmacology, 4th ed. A.F. Schatzberg & C.B. Nemeroff (eds.), pp. 1171-1199.Washington, D.C.: American Psychiatric Publishing.
22. Davis, L., Davidson, J.R.T.,Ward, L.C., et al. (2008). Divalproex in the treatment of posttraumatic stress disorder: A randomized, double-blind, placebo-controlled trial in a veteran population. Journal of Clinical Psychopharmacology, 28, 84-88.
23. Derogatis, L. (1975). Brief Symptom Inventory. Baltimore: Clinical Psychometric Research.
24. Dinarello, C.A. (2006). The paradox of pro-inflammatory cytokines in cancer. Cancer and Metastasis Reviews, 25, 307-313. (Pubitemid 44922351)
25. DuHamel, K.N., Ashman, T., Keane, T.M., et al. (2004). Construct validity of the posttraumatic stress disorder checklist in cancer survivors: Analysis based on two samples. Psychological Assessment, 16, 255-266. (Pubitemid 39244710)
26. First, M.B., Spitzer, R.L., Gibbon, M., et al. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
27. Floyd, F.J. & Widaman, K.F. (1995). Factor analysis in the development and refinement of clinical assessment instruments. Psychological Assessment, 7, 286-299.
28. Foa, E.B., Keane, M.J., Friedman, M.J., et al. (2008). Effective Treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies, 2nd ed. New York: Guilford Press.
29. Frankl, V.E. (1992). Man's Search for Meaning: An Introduction to Logotherapy, 4th ed. Boston: Beacon Press.
30. Green, B.L., Rowland, J.H., Krupnick, J.L., et al. (1998). Prevalence of posttraumatic stress disorder (PTSD) in women with breast cancer. Psychosomatics, 32, 102.
31. Greenstein, M. & Breitbart, W. (2000). Cancer and the experience of meaning: A group psychotherapy program for people with cancer. American Journal of Psychotherapy, 54, 486-500. (Pubitemid 32905614)
32. Gurevich, M., Devins, G.M. & Rodin, G.M. (2002). Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics, 43, 259-281.
33. Hamner, M.B., Faldowski, R.A., Robert, S., et al. (2009). A preliminary controlled trial of divalproex in posttraumatic stress disorder. Annals of Clinical Psychiatry, 21, 89-94.
34. Heim, C. & Nemeroff, C.B. (2009). Neurobiology of posttraumatic stress disorder. CNS Spectrums, 14, 13-24.
35. Horowitz, M., Wilner, N. & Alvarez, W. (1979). Impact of Event Scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209-218. (Pubitemid 9219271)
36. Jim, H.S.L. & Jacobsen, P.B. (2008). Posttraumatic stress and posttraumatic growth in cancer survivorship: A review. The Cancer Journal, 14, 414-419.
37. Kangas, M., Henry, J.L. & Bryant, R.A. (2002). Posttraumatic stress disorder following cancer: A conceptual and empirical review. Clinical Psychology Review, 22, 499-524. (Pubitemid 34462891)
38. Kessler, R.C., Berglund, P., Demler, O., et al. (2005a). Lifetime prevalence and age-of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602. (Pubitemid 40973434)
39. Kessler, R.C., Chiu, W.T., Demler, O., et al. (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 617-627. (Pubitemid 40973437)
40. Kiecolt-Glaser, J.K., Loving, T.J., et al. (2005). Hostile marital interactions, proinflammatory cytokine production, and wound healing. Archives of General Psychiatry, 62, 266-272.
41. Lethborg, C.E., Kissane, D., Burns,W.I., et al. (2000). "Cast adrift": The experience of completing treatment among women with early stage breast cancer. Journal of Psychosocial Oncology, 18, 73-90. (Pubitemid 32048048)
42. Ma, A.M.T., Barone, J.,Wallis, A.E., et al. (2008). Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. The American Journal of Surgery, 196, 500-504.
43. Maes, M., Song, C., Lin, A., et al. (1998). The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th-1 like response in stress-induced anxiety. Cytokine, 10, 313-318. (Pubitemid 28227076)
44. Maes, M., Lin, A., Delmeire, L., et al. (1999). Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in post-traumatic stress disorder following accidental man-made traumatic events. Biological Psychiatry, 45, 833-839. (Pubitemid 29185473)
45. Mason, J.W.,Wang, S., Yehuda, R., et al. (2002). Marked lability in urinary cortisol levels in subgroups of combat veterans with posttraumatic stress disorder during an intensive exposure treatment program. Psychosomatic Medicine, 64, 238-246. (Pubitemid 34260461)
46. McDade, T.W., Hawkley, L.C. & Cacioppo, J.T. (2006). Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: The Chicago health, aging and social relations study. Psychosomatic Medicine, 68, 376-381. (Pubitemid 44297667)
47. McNally, R.J. (2003). Progress and controversy in the study of posttraumatic stress disorder. Annual Review of Psychology, 54, 229-252. (Pubitemid 37417493)
48. Miller, A.H. (2009). Norman Cousins Lecture: Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface. Brain, Behavior, and Immunity, 23, 149-158.
49. Miller, A.H., Ancoli-Israel, S., Bower, J.E., et al. (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology, 26, 971-982. (Pubitemid 351409339)
50. Miller, A.H., Maletic, V. & Raison, C.L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732-741.
51. Mundy, E. & Baum, A. (2004). Medical disorders as a cause of psychological trauma and posttraumatic stress disorder. Current Opinion in Psychiatry, 17, 123-128.
52. Musselman, D.L., Lawson, D.H., Gumnick, J.F., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alpha. New England Journal of Medicine, 344, 961-966. (Pubitemid 32240314)
53. Paulus, M.P., Feinstein, J.S., Simmons, A., et al. (2004). Anterior cingulate activation in high trait anxious subjects is related to altered error processing during decision making. Biological Psychiatry, 55, 1179-1187. (Pubitemid 38739452)
54. Schnurr, P.P. & Spiro, A. (1999). Combat exposure, posttraumatic stress disorder symptoms, and health behaviors as predictors of self-reported physical health in older veterans. The Journal of Nervous and Mental Disease, 187, 353-359. (Pubitemid 29272886)
55. Shelby, R.A., Golden-Kreutz, D.M. & Andersen, B.L. (2005). Mismatch of posttraumatic stress disorder (ptsd) symptoms and DSM-IV symptom clusters in a cancer sample: Exploratory factor analysis of the ptsd checklist-civilian version. Journal of Traumatic Stress, 18, 347-357. (Pubitemid 46421983)
56. Smith, M.Y., Redd, W., DuHamel, K., et al. (1999). Validation of the PTSD checklist-civilian version in survivors of bone marrow transplantation. Journal of Traumatic Stress, 12, 485-499. (Pubitemid 29398631)
57. Stearns, V., Johnson, M.D., Rae, J.M., et al. (2003). Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. Journal of the National Cancer Institute, 95, 1758-1764. (Pubitemid 38008898)
58. Stein, M.B.,Walker, J.R., Haze, A.L., et al. (1997). Full and partial posttraumatic stress disorder: findings from a community survey. American Journal of Psychiatry, 154, 1114-1119.
59. Taylor, S., Kuch, K., Koch,W.J., et al. (1998). The structure of posttraumatic stress symptoms. Journal of Abnormal Psychology, 107, 154-160. (Pubitemid 28102963)
60. Tedeschi, R.G. & Calhoun, L.G. (2004). Posttraumatic growth: conceptual foundations and empirical evidence. Psychological Inquiry, 15, 1-18. (Pubitemid 38430320)
61. Van, der Kolk, B.A. & McFarlane, A.C. (1996). The black hole of trauma. In: Traumatic Stress: The Effects of Overwhelming Experience on Mind, Body, and Society. B.A. Van der Kolk, A.D. McFarlane & L. Weisaeth (eds.), pp. 3-23. New York: Guilford Press.
62. Ware, J. & Sherbourne, C. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30, 473-483.
63. Watson, C. (1990). Psychometric posttraumatic stress disorder measurement techniques: A review. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 2, 460-469.
64. Weathers, F.W., Litz, B.T., Herman, D.S., et al. (1993). The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. Presented at the Annual Meeting of International Society for Traumatic Stress Studies, San Antonio, Texas, October.
65. Yap, K.Y-L, Tay, W.L., Chui, W.K., et al. (2011). Clinically relevant drug interactions between anticancer drugs and psychotropic agents. European Journal of Cancer Care, 20, 6-32.